Fundraising for UK Healthtech Startups: The 2026 Guide
Healthtech investors want a defined regulatory pathway (UKCA/CE for devices, DTAC for NHS software) and clear evidence of clinical or economic outcomes.
What healthtech investors expect
Healthtech investors want a defined regulatory pathway (UKCA/CE for devices, DTAC for NHS software) and clear evidence of clinical or economic outcomes.
Benchmarks: NHS pilots signed, published evidence in a peer-reviewed journal, and a reimbursement or procurement pathway mapped out before Series A.
Reliefs and schemes: SBRI Healthcare, NIHR i4i, and Innovate UK Biomedical Catalyst are the main non-dilutive routes. SEIS/EIS still apply for the software layer.
Common traps: Assuming NHS pilots convert to paid contracts (they usually don't without a national framework), and under-scoping regulatory costs by 3–5x.
Healthtech fundraising by city
Frequently asked questions
How much can a healthtech startup in the UK typically raise at seed?
Typical UK seed rounds range from £400k to £2.5m depending on sector, location, and founder track record.
Which investors back healthtech companies in the UK?
Use RaiseAxis's investor database to filter 7,000+ UK-active funds by sector and geography.
What metrics do healthtech investors want to see?
NHS pilots signed, published evidence in a peer-reviewed journal, and a reimbursement or procurement pathway mapped out before Series A.
Can I use SEIS or EIS for this round?
SBRI Healthcare, NIHR i4i, and Innovate UK Biomedical Catalyst are the main non-dilutive routes. SEIS/EIS still apply for the software layer.
What's the biggest fundraising mistake to avoid?
Assuming NHS pilots convert to paid contracts (they usually don't without a national framework), and under-scoping regulatory costs by 3–5x.
Running a UK raise?
RaiseAxis gives you the investor CRM, deck analytics, data room, and 7,000+ investor database in one workspace. £1 for 7 days, cancel anytime.
Start £1 trial